BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Business

  MicroVention’s New SoCal Facility Will House More Than 800 Employees

  June 1, 2015

   · 

  3 min read
• Drug Development

  ASCO15: Exelixis Release:Updated Positive Results From Two Trials Of Cobimetinib In Combination With Vemurafenib For The Treatment Of Patients With Advanced Melanoma Presented At 2015 ASCO Annual Meeting

  June 1, 2015

   · 

  11 min read
• Drug Development

  Genentech’s Gazyva Extended The Time People With Refractory Indolent Non-Hodgkin’s Lymphoma Lived Without Their Disease Worsening

  June 1, 2015

   · 

  14 min read
• Week In Review: 3SBio Inc. To Stage $712 Million Hong Kong IPO

  June 1, 2015

   · 

  1 min read
• Drug Development

  DNA Therapeutics Presents Encouraging Results For First-In-Class Pan DNA Repair Inhibitor

  June 1, 2015

   · 

  4 min read
• Drug Development

  ASCO15: Momenta To Present New Data From Phase 1 Trial Of Necuparanib In Patients With Pancreatic Cancer

  June 1, 2015

   · 

  6 min read
• Pharm Country

  New Study Shows Cefaly Returns Normal Metabolic Activity To Brain Areas In Migraine Patients

  June 1, 2015

   · 

  2 min read
• Business

  Poseida Therapeutics Expands Into JLABS To Foster Research Collaboration With Janssen Pharmaceutical For Development Of Allogeneic CAR-T Therapies

  June 1, 2015

   · 

  3 min read
• Drug Development

  OncoGenex Pharmaceuticals Inc. Announces Data From Borealis-1 Trial Showing Clinical Benefit With Apatorsen In Metastatic Bladder Cancer

  June 1, 2015

   · 

  8 min read
• Drug Development

  ASCO15: Pfizer Announces Palbociclib More Than Doubled Progression-Free Survival In Phase 3 Trial For Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy

  June 1, 2015

   · 

  13 min read